Results 191 to 200 of about 2,335,008 (261)

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Correction: Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017. [PDF]

open access: yesBreast Cancer
Tanaka K   +21 more
europepmc   +1 more source

Advancing paramedical education through virtual learning platforms: A quantitative study at AJA University of Medical Sciences. [PDF]

open access: yesJ Educ Health Promot
Najafi Shahvalad Sofla P   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy